Application of combination of mTOR inhibitor and EPAS1 inhibitor in preparation of medicine for treating myeloproliferative tumors
CN121313848A · Application publication visible
Patent Applicant View
ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY
Explore source-linked longevity patent families and topic connections associated with the applicant name ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY.
Applicant activity
1 source-linked patent families
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.